INS and Hypoglycemia: The reduced magnitude of glucose levels following administration of the co‐formulation is an unexpected, but advantageous, effect since it combines coverage of mealtime glucose spikes with a reduced risk of insulin stacking or post‐prandial hypoglycemia.